Aura Biosciences, Inc. financial data

Symbol
AURA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
80 Guest Street, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.83K % +3.85%
Debt-to-equity 14.2 % -14.1%
Return On Equity -41.5 % +0.05%
Return On Assets -36.3 % -1.96%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.6M shares +29.9%
Common Stock, Shares, Outstanding 49.6M shares +30.2%
Entity Public Float 225M USD -19.8%
Weighted Average Number of Shares Outstanding, Basic 49.5M shares +30.9%
Weighted Average Number of Shares Outstanding, Diluted 49.5M shares +30.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 69.6M USD +29%
General and Administrative Expense 20.7M USD +6.68%
Operating Income (Loss) -90.3M USD -23.1%
Nonoperating Income (Expense) 9.84M USD +90.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -20.3M USD -11.1%
Income Tax Expense (Benefit) 46K USD
Net Income (Loss) Attributable to Parent -80.7M USD -18.3%
Earnings Per Share, Basic -1.8 USD/shares +10%
Earnings Per Share, Diluted -1.8 USD/shares +10%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.1M USD -37%
Cash, Cash Equivalents, and Short-term Investments 149M USD +33.7%
Other Assets, Current 2.47M USD +150%
Assets, Current 196M USD +17.7%
Property, Plant and Equipment, Net 3.33M USD -34.1%
Operating Lease, Right-of-Use Asset 18.1M USD -9.31%
Other Assets, Noncurrent 443K USD -36.7%
Assets 218M USD +13.3%
Accounts Payable, Current 1.46M USD +164%
Liabilities, Current 10.5M USD +18.6%
Operating Lease, Liability, Noncurrent 16.3M USD -6.47%
Liabilities 26.8M USD +2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -183K USD +17.9%
Retained Earnings (Accumulated Deficit) -327M USD -32.7%
Stockholders' Equity Attributable to Parent 191M USD +15%
Liabilities and Equity 218M USD +13.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.5M USD -49%
Net Cash Provided by (Used in) Financing Activities 253K USD +25.9%
Net Cash Provided by (Used in) Investing Activities 9.4M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 49.6M shares +30.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.8M USD +82.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.8M USD -36.4%
Deferred Tax Assets, Valuation Allowance 81.9M USD +36.5%
Deferred Tax Assets, Gross 87.3M USD +32.7%
Operating Lease, Liability 19M USD -6.77%
Depreciation 1.27M USD +1.92%
Payments to Acquire Property, Plant, and Equipment 88K USD -19.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -80.6M USD -18%
Lessee, Operating Lease, Liability, to be Paid 28.9M USD -10.8%
Property, Plant and Equipment, Gross 8.99M USD -5.58%
Operating Lease, Liability, Current 2.75M USD -8.44%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.41M USD +3.15%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.31M USD +3.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.89M USD -17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.51M USD +3.15%
Deferred Tax Assets, Operating Loss Carryforwards 46M USD +13.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.61M USD +3.11%
Operating Lease, Payments 751K USD -2.21%
Additional Paid in Capital 519M USD +25.6%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 11M USD +48.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%